The impact of prostate biopsy on erectile and ejaculatory function: A prospective study
https://doi.org/10.4081/aiua.2022.4.420
Accepted: September 16, 2022
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Objective: To evaluate the impact on erectile and ejaculatory function following transrectal ultrasound-guided biopsies of the prostate (TRUS-Bx) in sexually active men.
Methods: Monocentric prospective study from May 2021 to January 2022 of consecutive patients with suspected prostate cancer [elevated prostate specific antigen (PSA) level and/or abnormal digital rectal examination] undergoing TRUS-Bx. The 15-item version of the International Index of Erectile Function (IIEF-15), Premature Ejaculation Diagnostic Tool (PDET) and short form of Male Sexual Health Questionnaire (MSHQ-EjD Short Form) were assessed before, one and three months after TRUS-Bx. The primary endpoint was to evaluate the risk of temporary post-biopsy erectile and/or ejaculatory dysfunctions. The statistical significance was set as p value < 0.05.
Results: A total of 276 consecutive patients were included in the study. The median age, PSA and biopsy cores were 65 years (IQR 59-69), 7 ng/ml (IQR 5-9.7) and 16 (IQR 12-16), respectively. We compared the IIEF subdomains before TRUS-Bx vs. one or three months: the erectile function (EF) decreased after one month (p<0.001) but recovered after three months (p=0.833); the Orgasmic Function (OF), the Sexual Desire (SD), the Intercourse Satisfaction (IS), the Overall Satisfaction (OS), and Total IIEF decreased significantly after both one and three months compared to pre-biopsy values (p < 0.05). As for ejaculatory function (EjF), PDET, MSHQ-EjD Short Form 1, 2, 3 and MSHQ-EjD Short Form 4 scores decreased significantly after one month (p < 0.001), but they returned to pre-biopsy values after 3 months: p = 0.538, p = 0.071 and p = 0.098, respectively.
Conclusions: Our study proved that EF, assessed through IIEF- 15, and ejaculatory function, assessed through PDET and MSHQ-EjD Short Form, were negatively affected by TRUS-Bx one month after the procedure and recovered after three months. Interestingly, the other IIEF-15 subdomains (OF, SD, IS, OS and Total) resulted as significantly reduced also after 3 months: this issue highlights the importance of carefully considering the indication to TRUS-Bx.
Culp, M.B., et al. Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates. Eur Urol, 2020. 77: 38.
Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol 2013;64:876-92
Imperatore V, Creta M, Di Meo S, Buonopane R, Longo N. et al. Intravesical administration of combined hyaluronic acid and chondroitin sulfate can improve symptoms in patients with refractory bacillus Calmette-Guerin-induced chemical cystitis: Preliminary experience with one-year follow-up. Arch Ital Urol Androl. 2018 Mar 31;90(1):11-14. doi: 10.4081/aiua.2018.1.11.PMID: 29633792.
Fujita K., Landis P., McNeil B.K., Pavlovich C.P.: Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol 2009; 182: pp. 2664-2669.
Mehta A, Kim WC, Aswad KG, Brunckhorst O, Ahmed HU, Ahmed K. Erectile Function Post Prostate Biopsy: A Systematic Review and Meta-analysis. Urology. 2021 Sep;155:1-8. doi: 10.1016/j.urology.2021.01.035. Epub 2021 Jan 29. PMID: 33524434.
Rosen RC, Riley A, Wagner G, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830
Symonds T, Perelman MA, Althof S, Giuliano F, Martin M, May K, et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007; 52: 565–573. PMID: 17275165
Rosen RC, Catania JA, Althof SE, Pollack LM, O'Leary M, Seftel AD, Coon DW. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology. 2007 May;69(5):805-9. doi: 10.1016/j.urology.2007.02.036. PMID: 17482908.
Zisman A, Leibovici D, Kleinmann J, Siegel YI, Lindner A. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol 2001;165:445–54.
Tuncel A et al (2014) Impact of transrectal prostate needle biopsy on erectile function: results of power Doppler ultrasonography of the prostate Kaohsiung J Med Sci 30(4)194–9 DOI: 10.1016/j.kjms.2013.11.004 PMID: 24656160
Glaser AP, Novakovic K and Helfand BT (2012) The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety Curr Urol Rep 13(6) 447–54 DOI: 10.1007/s11934-012-0277-6 PMID: 22935886
Chrisofos M, Papatsoris AG, Dellis A, Varkarakis IM, Skolarikos A, Deliveliotis C. Can prostate biopsies affect erectile function? Andrologia 2006;38:79-83.
Koosha Kamali, Mostafa Nabizadeh, Mojtaba Ameli, Maryam Emami, Mohadese Mahvari-Habibabadi and Minoo Amirpoor “Impact of prostate needle biopsy on erectile function: A prospective study” Urologia Journal https://doi.org/10.1177/0391560319834488
Korfage IJ, Essink-Bot ML, Janssens AC, Schroder FH, de Koning HJ. Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 2006;94:1093–8.
Song PH, Lee KS, Choi JY, Ko YH, Jung HC, Moon KH. 1012 When does ejaculatory dysfunction recover after transrectal ultrasound guided prostate biopsy? Eur Urol Suppl. 2016;15:e1012. https://doi.org/10.1016/s1569-9056(16)61013-8.
Verze P, La Rocca R, Spirito L, Califano G, Venturino L, Napolitano L. Premature Ejaculation patients and their partners: arriving at a clinical profile for a real optimization of the treatment. Arch Ital Urol Androl. 2021 Mar 18;93(1):42-47. doi: 10.4081/aiua.2021.1.42.PMID: 33754608
Copyright (c) 2022 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
